Published date: 5 March 2024
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£384,770,000
Procurement reference
CF-2216400D0O000000rwimUAA
Published date
5 March 2024
Closing date
5 April 2024
Closing time
1pm
Contract start date
1 September 2024
Contract end date
31 August 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project title: NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024
Offer reference number: CM/PHR/22/5689
CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
More information
Attachments
-
- Document No. 05a(i) - Selectt Offer File - CM_PHR_22_5689_01.xml
- Document No. 05a(i) - Selectt Offer File - CM_PHR_22_5689_01
-
- Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_22_5689_02.xlsx
- Document No. 05b(ii) - Tender Product Listing and Usage - CM_PHR_22_5689_02
-
- Document No. 05a(iii) - Selectt Offer File - CM_PHR_22_5689_03.xml
- Document No. 05a(iii) - Selectt Offer File - CM_PHR_22_5689_03
-
- Document No. 02 - Terms of offer - CM_PHR_22_5689.doc
- Document No. 02 - Terms of offer - CM_PHR_22_5689
-
- Document No. 05c - Variant Offer Schedule - CM-PHR-22-5689.xls
- Document No. 05c - Variant Offer Schedule - CM-PHR-22-5689
-
- Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_22_5689_01.xlsx
- Document No. 05b(i) - Tender Product Listing and Usage - CM_PHR_22_5689_01
-
- Document No. 05 - Selectt offer schedule instructions - CM_PHR_22_5689.doc
- Document No. 05 - Selectt offer schedule instructions - CM_PHR_22_5689
-
- Document No. 07a - Quality control technical sheet - CM_PHR_22_5689.doc
- Document No. 07a - Quality control technical sheet - CM_PHR_22_5689
-
- Document No. 09 - Tender Design and Instructions on completing Document 05a - CM_PHR_22_5689.doc
- Document No. 09 - Tender Design and Instructions on completing Document 05a - CM_PHR_22_5689
-
- Document No. 05b(iii) - Tender Product Listing and Usage - CM_PHR_22_5689_03.xlsx
- Document No. 05b(iii) - Tender Product Listing and Usage - CM_PHR_22_5689_03
-
- Document No. 01 - Invitation to offer covering letter - CM_PHR_22_5689.doc
- Document No. 01 - Invitation to offer covering letter - CM_PHR_22_5689
-
- Document No. 03 - Framework Agreement and Terms and Conditions - CM_PHR_22_5689.docx
- Document No. 03 - Framework Agreement and Terms and Conditions - CM_PHR_22_5689
-
- Document No. 04a - Quality Assurance Process - CM_PHR_22_5689.doc
- Document No. 04a - Quality Assurance Process - CM_PHR_22_5689
-
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM_PHR_22_5689.docx
- Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements - CM_PHR_22_5689
-
- Document No. 05a(ii) - Selectt Offer File - CM_PHR_22_5689_02.xml
- Document No. 05a(ii) - Selectt Offer File - CM_PHR_22_5689_02
-
- Document No. 06 - Form of offer - CM_PHR_22_5689.doc
- Document No. 06 - Form of offer - CM_PHR_22_5689
-
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).pdf
- Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023)
-
- Document No. 08 - Confidential information schedule - CM_PHR_22_5689.xls
- Document No. 08 - Confidential information schedule - CM_PHR_22_5689
-
- Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5689.xls
- Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5689
Additional text
-
To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.
Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:
Phone: 0800 9956035
E-mail: support-health@atamis.co.uk
About the buyer
Contact name
Katie Noonan
Address
Rutland House
Runcorn
WA7 2ES
GB
Share this notice
Closing: 5 April 2024, 1pm